Laboratório Cirúrgico de Pesquisa Cardiovascular (LIM-11), Instituto do Coração (Incor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Laboratório Cirúrgico de Pesquisa Cardiovascular (LIM-11), Instituto do Coração (Incor), Hospital das Clínicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Pulm Pharmacol Ther. 2020 Apr;61:101901. doi: 10.1016/j.pupt.2020.101901. Epub 2020 Feb 7.
Lung transplantation is a treatment method for end stage lung disease, but the availability of donor lungs remains a major constraint. Brain death (BD) induces hemodynamic instability with microcirculatory hypoperfusion and increased inflammation, leading to pulmonary dysfunction. Hypertonic saline solution (HSS) is a volume expander possessing immunomodulatory effects. This study evaluated the influence of HSS on pulmonary dysfunction and inflammation in a rat model of BD.
BD was induced by inflation of an intracranial balloon catheter. Rats were divided into [1]: Sham, without BD [2]; NS, NaCl treatment (0.9%, 4 mL/kg, i.v.) immediately after BD [3]; HSS, HSS treatment (NaCl 7.5%, 4 mL/kg, i.v.) immediately after BD; and [4] HSS, HSS treatment 60 min post BD. All groups were analyzed after 360 min.
Animals subjected to BD exhibited increased exhaled O and decreased CO.The number of leukocytes in the lungs was significantly increased in the NS group (p = 0.002) and the HSS treatment was able to reduce it (HSS, p = 0.018 and HSS = 0.030). In parallel, HSS-treated rats showed reduced levels of ICAM-1 expression, which was increased in the NS compared to Sham group. Lung edema was found increased in the NS group animals compared to Sham and no effect of the HSS treatment was observed. There were no differences among the groups in terms of TNF-α, VEGF, and CINC-1 lung concentrations.
HSS is capable of reducing inflammatory cell infiltration into the lung after BD induction, which is associated with the reduction of ICAM-1 expression in organ vessels.
肺移植是治疗终末期肺病的一种方法,但供体肺的可用性仍然是一个主要限制。脑死亡(BD)会导致血液动力学不稳定,微循环灌注不足和炎症增加,从而导致肺功能障碍。高渗盐水溶液(HSS)是一种具有免疫调节作用的容量扩张剂。本研究评估了 HSS 对 BD 大鼠模型中肺功能障碍和炎症的影响。
通过颅内气囊导管充气诱导 BD。大鼠分为[1]:假手术组,无 BD;[2]:NS 组,BD 后立即给予生理盐水(0.9%,4 mL/kg,静脉注射);[3]:HSS 组,BD 后立即给予 HSS(NaCl 7.5%,4 mL/kg,静脉注射);[4]:HSS 组,BD 后 60 分钟给予 HSS。所有组均在 360 分钟后进行分析。
BD 动物表现出呼气 O 增加和 CO 减少。NS 组肺白细胞数量明显增加(p=0.002),HSS 治疗可减少白细胞数量(HSS,p=0.018 和 HSS=0.030)。同时,HSS 治疗组大鼠 ICAM-1 表达降低,NS 组与 Sham 组相比增加。与 Sham 组相比,NS 组动物的肺水肿增加,而 HSS 治疗没有观察到效果。TNF-α、VEGF 和 CINC-1 肺浓度在各组之间没有差异。
HSS 能够减少 BD 诱导后肺内炎症细胞浸润,这与器官血管中 ICAM-1 表达减少有关。